Literature DB >> 6186258

Decrease of serum pyridoxal phosphate levels and homocystinemia after administration of 6-azauridine triacetate and their prevention by administration of pyridoxine.

M Slavik, K J Smith, O Blanc.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6186258     DOI： 10.1016/0006-2952(82)90664-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  3 in total

1.  Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion.

Authors:  C J Fabian; R Molina; M Slavik; S Dahlberg; S Giri; R Stephens
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

2.  Hydrolysis of the prodrug, 2',3',5'-triacetyl-6-azauridine.

Authors:  C M Riley; M A Mummert; J Zhou; R L Schowen; D G Vander Velde; M D Morton; M Slavik
Journal:  Pharm Res       Date:  1995-09       Impact factor: 4.200

3.  Novel spectrophotometric method for the quantitation of urinary xanthurenic acid and its application in identifying individuals with hyperhomocysteinemia associated with Vitamin B₆ deficiency.

Authors:  Chi-Fen Chen; Tsan-Zon Liu; Wu-Hsiang Lan; Li-An Wu; Chin-Hung Tsai; Jeng-Fong Chiou; Li-Yu Tsai
Journal:  Biomed Res Int       Date:  2013-09-16       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.